Browse by Medical Category
Accepting New Patients
Go To Programs
Go To Specialties
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Chabner has had extensive experience in the field of cancer drug discovery and development. During his career at the National Cancer Institute, he served as a Senior Investigator in the Laboratory of Chemical Pharmacology, Chief of the Clinical Pharmacology Branch, Director of the Clinical Oncology Program, and Director of the Division of Cancer Treatment.
At the NCI, he maintained an active laboratory program in cancer pharmacology, and led the development of Taxol. His research contributed significantly to the development of high dose chemotherapy regimens, and to standard therapies for lymphoma.
Dr. Chabner is a senior editor for the Oncologist and serves on the executive advisory boards for some of the industry's leading innovators in drug development. In 2006, Dr. Chabner received a presidential appointment to the National Cancer Advisory Board at the NCI.
View my most recent publications at PubMed
Bruce Chabner, MD, director of Clinical Research for the MGH Cancer Center, was the recipient of an honorary Doctorate of Medical Sciences from the Queen's University of Belfast, Northern Ireland.
MGH Hotline 12.10.10 A named chair is one of the highest honors a physician may receive in his or her lifetime.
Back to Top